The Victoza injury case attorneys at the Drug Law Center are currently reviewing and pursuing antidiabetic lawsuits for clients who were injured or died prematurely from taking the injectable prescription.
Victoza (liraglutide) is a prescription medication designed to improve blood sugar levels in adults suffering from Type 2 diabetes and obesity.
The History of Victoza
Novo Nordisk manufactures the injectable once a day medicine designed to mimic the GLP-1 (glucagon-like peptide 1 receptor antagonist) hormone that delays stomach emptying and suppresses postprandial glucagon release while increasing insulin sensitivity. The pharmaceutical company began marketing the same product in a different strength under their brand-name Saxenda in both the United States and the European Union. Patients can self-inject the medication subcutaneously (under the skin) and not in a muscle or vein.
When the medication as prescribed in high doses, can help individual suffering with Type II diabetes lose pounds and inches. However, Victoza was approved to be used as a diabetic treatment. Alternatively, Saxenda has the same active ingredient liraglutide as Victoza, only in higher doses to generate more weight loss.
Treating Type II Diabetes
Victoza (liraglutide) was designed to improve the control of blood glucose levels and reduce hyperglycemia after meals. It does this by increasing insulin secretion when necessary. In addition, the drug decreases the patient’s appetite to stop body weight gain while lowering blood triglyceride levels. In addition, the medication stimulates insulin secretion only when there is a higher than normal level of blood glucose in the body and can inhibit apoptosis (programmed cell death).
Thyroid Cancer and Victoza
Clinical trials involving rats given Victoza and its generic form liraglutide showed a correlation of thyroid tumors and the medication. However, the clinical relevance has yet to be determined. The Food and Drug Administration said that a medullary thyroid cancer biomarker (serum calcitonin) had risen slightly in patients taking the generic form of Victoza. However, the results were still within normal range. The federal agency determined that it would likely take 15 years of ongoing monitoring to determine the relevancy of taking Victoza to see if it developed thyroid cancer.
Pancreatitis and Victoza
2013 – A report by Johns Hopkins reveal the correlation between the development of acute pancreatitis with a previous treatment of sitagliptin (DPP-4 inhibitor) and exenatide (a GLP-1 derivative) and the development of pancreatitis. However, the conclusion of numerous reports has yet been reached in the increased risk of developing can create a cancer pancreatitis and taking the medication.
Liraglutide-Relate Kidney Failure
The Food and Drug Administration has placed the drug maker on notice to include additional warnings on the Victoza Black box labeled to inform consumers of missing information. This includes that the product can cause existing chronic renal failure to become worse. In addition, the FDA wants Novo Nordisk to include that the medication can cause acute renal failure. Common symptoms of these 2 conditions include:
- Confusion and fatigue
- Shortness of breath
- Swelling of ankles, legs, or feet
- Fluid retention
- Minimal urine output
- Colmar seizures
- Chest pressure or pain
Victoza Side Defects
Patients are usually directed to inject Victoza subcutaneously. The doctor will likely recommend numerous injection sites including the upper arm, fight, or abdomen. The medication is given one time every day. Like most prescription drugs developed for the treatment of type II diabetes mellitus, Victoza has serious to severe side effects. The most common side effects experienced by individuals taking Victoza and its generic form liraglutide include:
- Skin rash
- Tired feeling
- Back pain
- Constipation or diarrhea
- Loss of appetite
- Upset stomach and indigestion
- Dizziness or headaches
- Cold symptoms including sinus pain, sore throat, sneezing, or stuffy nose
- Rash or redness at the injection site
Serious side effects in taking Victoza include:
- Thyroid tumors
- Thyroid cancer
- Allergic reactions involving shortness of breath, difficulty in swallowing, hoarseness, swelling or lumps in the neck
- Kidney failure
- Pancreatic cancer
- Pancreatic hemorrhaging
- Pancreatitis (pancreatic inflammation)
- Vomiting or nausea
- Severe back pain and abdominal pain
Who Should Avoid Taking Victoza?
Any patient can suffer an allergic or hypersensitivity reaction to a new medication, including Victoza or its generic form liraglutide, which should be avoided when necessary. The medication is contraindicated in individuals with a family or personal history of MTC (medullary thyroid carcinoma) or those with Type 2 Multiple Endocrine Neoplasia Syndrome.
Victoza is not to be prescribed as a substitute for taking insolent and does not treat diabetic ketoacidosis or Type I diabetes mellitus.
Even before the medicine was first introduced into the medical marketplace, numerous agencies and researchers were questioning problems associated with taking Victoza. Even so, the FDA approved the medication. However, by 2012 a consumer advocate group filed a petition calling for a Victoza recall by asking the Food and Drug Administration to remove the medicine from the medical marketplace. To date, no recall has yet to be initiated by the federal agency or voluntarily by the drug maker.
2011 – A Food and Drug Administration Safety Communication Announcement in June revealed the federal agency had received reports of more than 200 cases involving acute pancreatitis and more than 25 cases involving pancreatic cancer involving patients taking Victoza. The FDA was warning consumers just beginning a new Victoza prescription that organ damage or death could occur from acute pancreatitis. Consumers were to observe the common symptoms and signs of pancreatitis that include persistent severe abdominal pain that radiates to the back that could include vomiting.
The previous month (May 2011), the FDA warned consumers of a kidney impairment caused by taking Victoza that could lead to hemodialysis. The federal agency noted that the drug manufacturer would need to inform consumers and doctors to use caution when prescribing the drug for the first time, or increasing doses of Victoza for individual suffering from renal impairment.
March 2013 – The Food and Drug Administration released a consumer safety communication noting that additional evaluation research would be conducted on Victoza and other incretin mimetic drugs to treat Type II diabetes. The FDA was concerned about the potential increase of developing pre-cancer cell changes and pancreatitis in patients taking Victoza and the generic form liraglutide. No conclusions following the research have been determined on the medication’s safety and efficacy.
- Victoza Wrongful Death Lawsuit Filed by Utah Widow against Drug MakerMarch 2012 – Novo Nordisk is facing another Victoza wrongful death lawsuit, this time filed by a Utah widow who alleges the injectable diabetic treatment prescription medication caused her deceased husband to develop pancreatic cancer that claimed his life. The plaintiff is seeking financial damages saying that the drug maker failed to warn her husband, doctors, and the medical community. The lawsuit is based on negligence, design defect, fraudulent concealment, negligent misrepresentation, and breach of warranties.
The plaintiff claims that her husband began taking Victoza in 2008 as prescribed by his doctor and continue to take the drug another 2.5 years. However, it was in 2011 when doctors diagnosed the widow’s husband as having pancreatic cancer side effects. The woman is complaining that Victoza failed to display safety warnings on their product of the known increased potential risk of developing pancreatitis and possibly pancreatic cancer. This lawsuit was filed in the US District Court, Southern District of California.
- Massachusetts Woman Files Victoza Pancreatic Cancer LawsuitMay 2013 – One more Victoza pancreatic cancer lawsuit has been filed against Novo Nordisk, this time from a Massachusetts woman who alleges that the medication caused the development of her pancreatic cancer. The plaintiff claims that in March 2009, her doctors prescribe Victoza as an effective way of controlling her Type II diabetes mellitus. However, in 2011 she stopped taking the medication after doctors diagnosed her with life-threatening pancreatic cancer.
The plaintiff is alleging that the drug maker was aware, or should have been aware, that Victoza produces serious side effects. Her attorneys are saying that not only did the drug maker know about the potential harm the diabetic treatment medication causes, but they went out of their way to conceal the potential risks and prevented the plaintiff and her doctors from having access to known information of the side effects before she made an informed medical decision. This lawsuit was filed in the US district court for the Southern District of California.
- Victoza Pancreatic Cancer Death Lawsuit Filed by a New York PlaintiffNovember 2013 – Another pancreatic Cancer death lawsuit has been filed against the pharmaceutical company who makes the anti-diabetic medication. The New York plaintiff alleges that Victoza, manufactured by Novo Nordisk, caused her mother to develop fatal pancreatic cancer that would ultimately claim her life. The plaintiff claims that Drs. prescribed her mother Victoza in late 2011 which she took until June 2012. By December 2011, doctors diagnosed her mother with pancreatic cancer. She succumbed to the disease In May 2013.
Plaintiff’s working on behalf of the client are suing the drug maker for manufacturing, selling, distributing, campaigning, and marketing the dangerous product for sale in the medical marketplace. The foundation of the lawsuit is based on negligence, product misrepresentation, false advertising and concealing information valuable to consumers wanting to be well-informed.
- Mississippi Widower Files a Victoza Pancreatic Cancer Wrongful Death LawsuitNovember 2013 – A Mississippi plaintiff has filed a wrongful death lawsuit against Novo Nordisk alleging that his wife died of pancreatic cancer that was developed after she took the Type II diabetes treatment medication. The man says his wife’s doctors initially prescribed her Byetta, a competing diabetic treatment drug in 2011 which she took until September 2012. During that time, the doctor also prescribed Victoza. It was in November 2012 the doctors diagnosed the plaintiff’s wife with fatal pancreatic cancer. She succumbed to the disease in January 2013.
The plaintiff is claiming that his wife, her doctors, and the medical community were not made aware of the potential complications of taking Victoza and that there were no indications or warnings on the label to notify consumers of dangerous side effects.
Currently Accepting Victoza Compensation Lawsuits
The Victoza injury Case lawyers at the Drug Law Center are an experienced team of litigators that focus on representing clients involved in Victoza lawsuits and compensation claims. We pursue cases involving individual litigation and class action lawsuits and are currently reviewing, evaluating, and accepting Victoza pancreatic cancer recompense cases through contingency fee arrangements. This means we postpone payment of our fees until after we have successfully resolved your case through a jury trial award or a negotiated settlement out of court.
If you have suffered injury or lost a loved one after they took Victoza due to pancreatic cancer, pancreatitis, thyroid cancer, kidney failure, or another serious side effect, you are likely entitled to file a claim or lawsuit for compensation. Contact us today so we can begin the process of representing you in your Victoza lawsuit litigation case. We are currently offering free case consultations to discuss the merits of your lawsuit. Our competent team of attorneys can provide you numerous legal options on the best way to pursue your case to ensure your family receives the highest amount of financial compensation available.